HomeInvesting NewsBurning Rock Biotech Stock Rises by Over 18% In Wake of FY...

Burning Rock Biotech Stock Rises by Over 18% In Wake of FY 2022 Revenue 

Published on

Burning Rock Biotech (NASDAQ:BNR)

In Wednesday afternoon trade, shares of Burning Rock Biotech (NASDAQ:BNR), a Chinese pharmaceutical company, increased 17.7% to US$3.83 after the company maintained its FY 2022 sales target despite a major impact from COVID-19 restrictions.

It is important to note that BNR stock had been rising prior to today’s earnings announcements, and shares were expected to close in the black for a fifth straight day.

BNR announced Q2 GAAP EPS of -$0.37 earlier today, below forecasts by $0.01. Its $19.5 million in revenue fell short of forecasts by $2.94 million.

Burning Rock Biotech reported that revenue from its in-hospital operations fell 15.6% year over year, primarily as a result of sharp drops in testing volume in Shanghai as a result of COVID lockdowns and, to a lesser extent, in Beijing.

However, according to BNR, the in-hospital business outside of Shanghai and Beijing, new products, and pharma service revenue have all demonstrated “great growth momentum.”

The company kept its RMB 620 million (US$88.9 million) revenue forecast for FY 2022.


Financials as reported revenue from Burning Rock Biotech was RMB78.6 million (US$11.7 million) for the 3 months ending on June 30, 2022, a 1.8% reduction from RMB80.0 million (US$11.6 million) for a similar period in 2021. Growth from recently announced products partially offset the negative impact of Covid. Sequentially, new product introductions were the primary cause of the central laboratory’s 5.9% sequential revenue growth when compared to the first quarter of 2022. 

Revenue from the in-hospital business was RMB34.2 million (US$5.1 million), for the three months ending June 30, 2022. This is a 15.6% decrease from RMB40.5 million (US$5.88 million) when compared to the same period in 2021. 

This decline was primarily caused by sharp drops in testing volume in Shanghai because of the Covid-19 lockdown and, to a lesser extent, drops in testing volume in Beijing; other regions outside of Shanghai and Beijing demonstrated strong growth.

Featured Image-  Megapixl @Iammotos

See Disclaimer Please

Latest News

Qcom Stock Screams Buy

Qualcomm stock (NASDAQ:QCOM) is one investment that investors may want to purchase by the...

What to Expect From Apple Stock in the Coming Days

Apple stock (NASDAQ:AAPL) has been losing ground over the last month, following the general...

Is Verizon a Good Buy or a Good Sell?

While VZ stock (NYSE:VZ) has regularly lagged behind the S&P 500, the telecoms behemoth...

Carmax Stock Falls as Q2 Earnings Miss, and Car Sales Fall.

CarMax stock (NYSE:KMX) plummeted significantly on Thursday after the vehicle-buying website revealed lower-than-expected second-quarter profitability...

More like this

The Reasons Why Tesla Stock Slipped Today

Tesla Stock (NASDAQ:TSLA) At 2:05 p.m. In early afternoon trading today at 2:00 p.m. ET,...

Shopify Stock Fell as the Company Announced a New POS Go Designed to Aid Retailers.

Shopify Stock (NYSE:SHOP) To help businesses of all sizes complete deals with clients anywhere, Shopify...

Walmart Stock Falls Despite the Retailer’s Recent Opening of a New Distribution Facility in Time for the Holidays.

Walmart Stock (NYSE:WMT) The supply chain of Walmart Inc. (NYSE:WMT) is on track for transformation...

Boeing Stock Dropped Despite the Firm Winning a $169 Million Contract to Support F/A-18E/F and E/A-18G Fighter Planes.

Boeing Stock (NYSE:BA) Boeing stock plunged, although the company recently won a contract involving the...

AAL Stock Is Down Due to Hurricane Ian, and Thousands of Flights Canceled

AAL stock declines as $12.18 as of 01:44PM EDT. On Thursday, a significant number of...

PTON Stock Declines as Dick’s Is Chosen as Its First Retail Partner

PTON stocks were trading at $6.85 as of 01:59 PM EDT. Just in time for...